Exploring Efavirenz-Emtricitabine-Tenofovir: Challenges in HIV Drug Resistance
Efavirenz-Emtricitabine-Tenofovir is a combination therapy widely used in managing HIV. However, the emergence of drug resistance poses a significant challenge to its long-term efficacy. Understanding the mechanisms of resistance and exploring strategies to overcome these challenges is crucial. This article provides insights into the factors contributing to resistance and offers practical tips for optimizing treatment outcomes.
Read More